Q3 2023 · 13F-HR
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2023-11-09 · accession 0000904454-23-000600
$271.5M
Reported value
24
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52490G102 | LEGN | Legend Biotech Corporation | $54.7M | 20.2% | 814,586 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $53.0M | 19.5% | 3,495,575 | Common | SHARED |
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $40.9M | 15.0% | 2,449,183 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $32.6M | 12.0% | 6,641,064 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $15.1M | 5.55% | 748,062 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $12.9M | 4.74% | 912,128 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $11.7M | 4.33% | 357,939 | Common | SHARED |
| 36118A100 | — | Fusion Pharmaceuticals Inc. | $9.5M | 3.52% | 3,670,516 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $8.4M | 3.09% | 959,637 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $7.2M | 2.64% | 3,379,064 | Common | SHARED |
| 730541109 | — | Point Biopharma Global Inc. | $6.7M | 2.46% | 1,000,000 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $6.7M | 2.45% | 247,598 | Common | SHARED |
| 01438T106 | ALDX | Aldeyra Therapeutics, Inc. | $2.6M | 0.97% | 394,834 | Common | SHARED |
| 229790100 | HLTHQ | Cue Health, Inc. | $2.5M | 0.90% | 5,548,864 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $2.3M | 0.84% | 1,074,658 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $2.1M | 0.77% | 317,704 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $998,653 | 0.37% | 728,944 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $750,958 | 0.28% | 2,133,402 | Common | SHARED |
| 83444K105 | SLGCUSD | SomaLogic, Inc. | $671,714 | 0.25% | 281,052 | Common | SHARED |
| 185063104 | CLSDUSD | Clearside Biomedical, Inc. | $147,560 | 0.05% | 169,629 | Common | SHARED |
| G0411D107 | APLM | Apollomics, Inc. | $49,629 | 0.02% | 13,252 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $32,986 | 0.01% | 54,621 | Common | SHARED |
| 14888D208 | — | Catalyst Biosciences, Inc. | $32,290 | 0.01% | 66,951 | Common | SHARED |
| 89237H209 | — | Tracon Pharmaceuticals, Inc. | $14,953 | 0.01% | 84,003 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.